HTB140 melanoma cells under proton irradiation and/or alkylating agents
Апстракт
Chemoresistance is a major problem in the treatment of malignant melanoma. The mainstay of treatment for melanoma is the DNA-alkylating agent dacarbazine (DTIC). Fotemustine (FM), a member of the chloroethylnitrosourea group of alkylating agents, has also demonstrated significant antitumor effects in malignant melanoma. However, the intrinsic and acquired resistance of melanoma limits the clinical application of these drugs. Melanomas are also extremely radioresistant. With the objective of enhancing growth inhibition of melanoma cells, combined treatments of FM or DTIC with proton irradiation have been investigated. These effects were studied on HTB140 melanoma cell viability and proliferation. Cells exposed to treatment with FM and protons have shown inhibition of cell growth and significant reduction of proliferation capacity compared to single irradiation or drug treatment. Treatment with DTIC and protons has shown improved growth inhibition compared to appropriate single drug trea...tment, while the effects of single proton irradiation have been the most pronounced.
Извор:
Russian Journal of Physical Chemistry A, 2007, 81, 9, 1467-1470Напомена:
- 8th International Conference on Fundamental and Applied Aspects of Physical Chemistry, Sep 26-29, 2006, Belgrade, Serbia
DOI: 10.1134/S0036024407090233
ISSN: 0036-0244; 1531-863X
WoS: 000253706400023
Scopus: 2-s2.0-34548510545
Колекције
Институција/група
VinčaTY - JOUR AU - Korićanac, Lela AU - Petrović, Ivan M. AU - Privitera, G. AU - Cuttone, Giacomo AU - Ristić-Fira, Aleksandra PY - 2007 UR - https://vinar.vin.bg.ac.rs/handle/123456789/6724 AB - Chemoresistance is a major problem in the treatment of malignant melanoma. The mainstay of treatment for melanoma is the DNA-alkylating agent dacarbazine (DTIC). Fotemustine (FM), a member of the chloroethylnitrosourea group of alkylating agents, has also demonstrated significant antitumor effects in malignant melanoma. However, the intrinsic and acquired resistance of melanoma limits the clinical application of these drugs. Melanomas are also extremely radioresistant. With the objective of enhancing growth inhibition of melanoma cells, combined treatments of FM or DTIC with proton irradiation have been investigated. These effects were studied on HTB140 melanoma cell viability and proliferation. Cells exposed to treatment with FM and protons have shown inhibition of cell growth and significant reduction of proliferation capacity compared to single irradiation or drug treatment. Treatment with DTIC and protons has shown improved growth inhibition compared to appropriate single drug treatment, while the effects of single proton irradiation have been the most pronounced. T2 - Russian Journal of Physical Chemistry A T1 - HTB140 melanoma cells under proton irradiation and/or alkylating agents VL - 81 IS - 9 SP - 1467 EP - 1470 DO - 10.1134/S0036024407090233 ER -
@article{ author = "Korićanac, Lela and Petrović, Ivan M. and Privitera, G. and Cuttone, Giacomo and Ristić-Fira, Aleksandra", year = "2007", abstract = "Chemoresistance is a major problem in the treatment of malignant melanoma. The mainstay of treatment for melanoma is the DNA-alkylating agent dacarbazine (DTIC). Fotemustine (FM), a member of the chloroethylnitrosourea group of alkylating agents, has also demonstrated significant antitumor effects in malignant melanoma. However, the intrinsic and acquired resistance of melanoma limits the clinical application of these drugs. Melanomas are also extremely radioresistant. With the objective of enhancing growth inhibition of melanoma cells, combined treatments of FM or DTIC with proton irradiation have been investigated. These effects were studied on HTB140 melanoma cell viability and proliferation. Cells exposed to treatment with FM and protons have shown inhibition of cell growth and significant reduction of proliferation capacity compared to single irradiation or drug treatment. Treatment with DTIC and protons has shown improved growth inhibition compared to appropriate single drug treatment, while the effects of single proton irradiation have been the most pronounced.", journal = "Russian Journal of Physical Chemistry A", title = "HTB140 melanoma cells under proton irradiation and/or alkylating agents", volume = "81", number = "9", pages = "1467-1470", doi = "10.1134/S0036024407090233" }
Korićanac, L., Petrović, I. M., Privitera, G., Cuttone, G.,& Ristić-Fira, A.. (2007). HTB140 melanoma cells under proton irradiation and/or alkylating agents. in Russian Journal of Physical Chemistry A, 81(9), 1467-1470. https://doi.org/10.1134/S0036024407090233
Korićanac L, Petrović IM, Privitera G, Cuttone G, Ristić-Fira A. HTB140 melanoma cells under proton irradiation and/or alkylating agents. in Russian Journal of Physical Chemistry A. 2007;81(9):1467-1470. doi:10.1134/S0036024407090233 .
Korićanac, Lela, Petrović, Ivan M., Privitera, G., Cuttone, Giacomo, Ristić-Fira, Aleksandra, "HTB140 melanoma cells under proton irradiation and/or alkylating agents" in Russian Journal of Physical Chemistry A, 81, no. 9 (2007):1467-1470, https://doi.org/10.1134/S0036024407090233 . .